Pediatricians recommend the annual seasonal influenza vaccination for everyone 6 months and older, including children and adolescents. However, they have withdrawn their recommendation for FluMist, citing “evidence for poor effectiveness.”
In June, the CDC recommended against using FluMist due to a lack of evidence regarding the vaccine’s efficacy. The CDC’s Advisory Committee on Immunization Practices based its recommendation on data that suggested the live nasal vaccine was highly effective until 2013, when the vaccine changed from covering three strains to four.
Pediatricians said special effort should be made to vaccinate:
- Children age 6 months and older with conditions that increase the risk of complications from influenza
- All household contacts and out-of-home care providers of children with high-risk conditions and those younger than 5 years old, especially infants younger than 6 months
- American Indian/Alaska Native children
- All healthcare personnel
- All child care providers and staff
- All women who are pregnant, are considering pregnancy, are in the postpartum period, or are breastfeeding during flu season
More articles on supply chain:
6 things to know about carfentanil: The deadly opioid invading the U.S.
Industry expert: EpiPens only cost $20 to make
6 states file civil rights complaints against insurers over HIV drug costs
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
